Aptevo Therapeutics Inc. — Director's Dealing 2017

Feb 27, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2017-02-24

Reporting Person: Stromatt Scott C (Chief Medical Officer and SVP)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-24	Stock Option (right to buy)	$1.96	A	33700	Acquired	2027-02-24	Common Stock (33700)	Direct

Footnotes

F1: The options vest in three equal annual installments beginning on February 24, 2018.